Tudor Investment Corp’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-40,866
| Closed | -$4.77M | – | 1575 |
|
|
2025
Q1 | $4.77M | Buy |
+40,866
| New | +$4.77M | 0.02% | 489 |
|
|
2024
Q4 | – | Sell |
-25,832
| Closed | -$2.32M | – | 1545 |
|
|
2024
Q3 | $2.32M | Buy |
25,832
+6,849
| +36% | +$616K | 0.01% | 701 |
|
|
2024
Q2 | $1.53M | Buy |
+18,983
| New | +$1.53M | 0.01% | 827 |
|
|
2023
Q3 | – | Sell |
-30,321
| Closed | -$2.18M | – | 1489 |
|
|
2023
Q2 | $2.18M | Buy |
30,321
+6,453
| +27% | +$464K | 0.03% | 628 |
|
|
2023
Q1 | $1.47M | Buy |
+23,868
| New | +$1.47M | 0.02% | 761 |
|
|
2022
Q4 | – | Sell |
-20,580
| Closed | -$918K | – | 1554 |
|
|
2022
Q3 | $918K | Sell |
20,580
-23,282
| -53% | -$1.04M | 0.02% | 851 |
|
|
2022
Q2 | $1.68M | Sell |
43,862
-34,105
| -44% | -$1.31M | 0.04% | 565 |
|
|
2022
Q1 | $3.23M | Buy |
77,967
+33,693
| +76% | +$1.39M | 0.08% | 331 |
|
|
2021
Q4 | $1.67M | Sell |
44,274
-46,055
| -51% | -$1.74M | 0.03% | 678 |
|
|
2021
Q3 | $2.98M | Buy |
90,329
+63,668
| +239% | +$2.1M | 0.05% | 412 |
|
|
2021
Q2 | $1.8M | Sell |
26,661
-16,667
| -38% | -$1.12M | 0.03% | 580 |
|
|
2021
Q1 | $2.45M | Buy |
43,328
+38,925
| +884% | +$2.2M | 0.05% | 422 |
|
|
2020
Q4 | $359K | Sell |
4,403
-8,978
| -67% | -$732K | 0.01% | 1050 |
|
|
2020
Q3 | $953K | Buy |
13,381
+7,002
| +110% | +$499K | 0.04% | 575 |
|
|
2020
Q2 | $525K | Buy |
+6,379
| New | +$525K | 0.03% | 701 |
|
|
2020
Q1 | – | Sell |
-23,473
| Closed | -$2.43M | – | 1047 |
|
|
2019
Q4 | $2.43M | Buy |
+23,473
| New | +$2.43M | 0.11% | 215 |
|